Sorcero, a leading Google Cloud healthcare and life science ecosystem partner, has developed a revolutionary generative AI (gen AI) solution for creating plain language summaries (PLS) of complex scientific content. This innovative approach aims to bridge the gap between scientific research and public understanding, making critical information more accessible...
VantAI, a leader in generative AI and drug discovery, announced the appointment of John Cuozzo, PhD as SVP, Head of Drug Discovery. Cuozzo is an experienced scientific leader with a strong track record of building novel discovery platforms and leading successful drug discovery programs. He brings over 20 years...
Nimbus Therapeutics, LLC, a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine, announced the appointment of Anita Scheuber, M.D., Ph.D., as Senior Vice President, Therapeutic Area Head, Oncology. In this role, Dr. Scheuber will lead the company’s clinical development strategy...
Cache DNA, Inc., a life sciences company revolutionizing biological sample and data storage infrastructure, announced the closing of its seed round. The team raised an undisclosed amount from notable investors, including Climate Capital Bio, Exor Ventures, Hawktail, LifeX Ventures, Pillar VC, and Trousdale Ventures, including support from Illumina and...
ACTO announced the launch of TalkTRx™, the first product designed to give reps access to marketing assets with layered context so they can deliver accurate presentations and more personal with health professionals. ACTO's TalkTRx is developed as part of the company's AI-powered Intelligent Field Excellence (IFE) platform, purpose-built for...
Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging the Company's strong leadership and financial position to acquire synergistic technologies and services. This initiative aims to further advance the company's internal research programs...
ODAIA is first company to join Veeva AI Partner Program and provide industry's first GenAI solution for Veeva Vault CRM
ODAIA announced it is expanding its product partnership with Veeva Systems, joining the Veeva AI Partner Program to advance the use of Generative AI (GenAI) in life sciences. As the first product partner...
The company is introducing OM1 Orion, OM1 Lyra, and OM1 Polaris, aligning AI technology and real-world data to offer unprecedented insights into the patient journey and further patient outcomes through prediction, precision, and discovery
OM1 introduces three new products: OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine...
QIAGEN announced the availability of QCI Secondary Analysis, a cloud-based software-as-a-services (SaaS) solution enabling high-throughput secondary analysis for use with any clinical next-generation sequencing (NGS) data.
This turnkey service supports all QIAGEN QIAseq panels and seamlessly integrates with QCI Interpret, QIAGEN’s clinical variant interpretation and reporting software, to deliver highly...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced the first commercial placement of the REM-I platform at Erasmus Medical Center in Rotterdam. This commercial milestone follows placements of pre-commercial instruments at laboratories in Europe and the U.S. for Beta testing. In addition,...
